GlobeNewswire Inc.··DelveinsightPharma Race Heats Up: 15+ Companies Chase Synovial Sarcoma Treatment Gold Rush
Over 15 pharmaceutical companies are advancing 20+ pipeline drugs for synovial sarcoma, a rare cancer with significant unmet medical need, using cutting-edge TCR-T and bispecific antibody approaches.
MRNAIMTXDSNKYADAPYclinical trialsdrug development